Leanne Ward MD, FRCPC

E-Card

Leanne Ward MD, FRCPC
Full Professor, Medical Director of the CHEO Bone Health Clinic, Scientific Director of the Ottawa Pediatric Bone Health Research Group

Research Chair in Pediatric Bone Health, University of Ottawa
Pediatric Endocrinologist, Division of Endocrinology and Metabolism, CHEO

Office: 613-737-2253
Work E-mail: lward@cheo.on.ca

Head shot of Dr. Ward

Biography

Dr. Leanne Ward is a Professor of Pediatrics at the University of Ottawa where she has held a Research Chair in Pediatric Bone Health since 2010. She is the Scientific Director of the Ottawa Pediatric Bone Health Research Group, the Medical Director of the Pediatric Bone Health Clinic at the Children’s Hospital of Eastern Ontario (CHEO), and a pediatric endocrinologist in the Division of Endocrinology and Metabolism at CHEO.

Dr. Ward’s research program is dedicated to the study of bone development and the diagnosis and treatment of bone disorders in children, including osteoporosis and rickets. She has been the principal investigator of the “STOPP” research program (STeroid-induced Osteoporosis in the Pediatric Population) since 2003, a pan-Canadian project funded by the Canadian Institutes of Health Research to evaluate the effect of glucocorticoids on bone health in children with chronic illnesses.  This multi-centre longitudinal research program has unveiled the natural history of osteoporotic fractures in children with steroid-treated disorders, including the clinical hallmark of this disorder in children, vertebral fractures. The results of the STOPP Consortium’s work under Dr. Ward’s leadership have played a major role in informing the approach to the diagnosis of steroid-induced osteoporosis in children, to the monitoring of those at risk, and in identifying children in need of osteoporosis prevention and intervention.

Leanne is actively involved in and leads a number of clinical trials for children with osteogenesis imperfecta, rickets (including X-linked hypophosphatemia), and chronic illness osteoporosis including Duchenne muscular dystrophy (DMD). She has served as an endocrinology and bone health advisor to various international organizations including the Centres for Disease Control Clinical Care Guidelines for DMD, the International Late Effects of Childhood Cancer Guideline Harmonization Group, the International Society for Clinical Densitometry and the International Conference on Children’s Bone Health.  She is the Founder and Chair of the Canadian Pediatric Bone Health Working Group, and a frequent invited speaker at international bone and endocrinology conferences.

Dr. Ward has published over 100 original peer-reviewed manuscripts, numerous book chapters, and has received awards for her work in pediatric bone health, including a Canadian Child Health Clinician Scientist Career Development Award, a Canadian Institutes for Health Research New Investigator Award, a Canadian Child Health Clinician Scientist Career Enhancement Award, and two, five-year Research Chairs in Pediatric Bone Health (University of Ottawa, 2010 and 2015).

In 2019, Dr. Ward was named a Fellow of the American Society of Bone and Mineral Research, an award in recognition of significant contributions to bone and mineral science.

Back to top